arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

ANGIODYNAMICS INC

ANGO
$15.69 ▲ +0.58 (+3.84%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
66 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

ANGIODYNAMICS INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth 8.0%
Op. Margin -11.8%
ROIC -6.2%
FCF / Share None
Trailing P/E
Price / Book 3.8x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

66-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$86.61M
↑ +8.0%
Net Income Profit after all expenses
$-11.40M
↓ -88.5%
Operating Margin Operating profit as % of sales
-11.8%
↑ +28.7% 12th
FCF / Share Free cash flow per share
$-0.10
↓ -197.2%
Long-Term Debt Long-term obligations
$0.00
↓ -100.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
15
Returns
20
Cash Quality
21

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 66 quarters